In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli

Vaccine

Volumn 27, Issue 32, 2009, Pages 4302-4308

  Liang, Shuang ^a   Hosur, Kavita B ^a   Nawar, Hesham F ^b   Russell, Michael W ^b   Connell, Terry D ^b   Hajishengallis, George ^a,c  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Dendritic cells; Heat labile enterotoxins; Mucosal adjuvants

Indexed keywords

ANTIBODY; ANTIGEN; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI LT IIB ENTEROTOXIN; IMMUNOLOGICAL ADJUVANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BETA CHAIN; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEGRADATION; DENDRITIC CELL; DRUG MECHANISM; ESCHERICHIA COLI; FEMALE; IMMUNIZATION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES; BACTERIAL TOXINS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; IMMUNITY, MUCOSAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEIN SUBUNITS;

EID: 67649518029     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.05.027     Document Type: Article

References (45)

1. Holmes R., Jobling M.G., and Connell T. Cholera toxin and related enterotoxins of Gram-negative bacteria. In: Moss J., Iglewski B., Vaughn M., and Tu A.T. (Eds). Bacterial toxins and virulence factors in disease. Handbook of natural toxins (1995), Marcel Dekker, Inc., New York 225-255
2. Connell T.D. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins. Expert Rev Vaccines 6 5 (2007) 821-834
3. Van Den Akker F., Sarfaty S., Twiddy E.M., Connell T., Holmes R.K., and Hol W.G.J. Crystal structure of a new heat-labile enterotoxin, LTIIb. Structure 4 6 (1996) 665-678
4. Gill D.M., Clements J.D., Robertson D.C., and Finkelstein R.A. Subunit number and arrangement in Escherichia coli heat-labile enterotoxin. Infect Immun 33 3 (1981) 677-682
5. Elson C.O., and Dertzbaugh M.T. Mucosal adjuvants. In: Mestecky J., Bienenstock J., Lamm M.E., Mayer L., Strober W., and McGhee J.R. (Eds). Mucosal immunology. 3rd ed. (2005), Elsevier/Academic Press, San Diego 967-986
6. Freytag L.C., and Clements J.D. Mucosal adjuvants. Vaccine 23 15 (2005) 1804-1813
7. Hajishengallis G., Arce S., Gockel C.M., Connell T.D., and Russell M.W. Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections. J Dent Res 84 12 (2005) 1104-1116
8. Peppoloni S., Ruggiero P., Contorni M., Morandi M., Pizza M., Rappuoli R., et al. Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. Expert Rev Vaccines 2 2 (2003) 285-293
9. Hajishengallis G., Nawar H., Tapping R.I., Russell M.W., and Connell T.D. The Type II heat-labile enterotoxins LT-IIa and LT-IIb and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells. Infect Immun 72 11 (2004) 6351-6358
10. Hajishengallis G., Tapping R.I., Martin M.H., Nawar H., Lyle E.A., Russell M.W., et al. Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins. Infect Immun 73 3 (2005) 1343-1349
11. Liang S., Wang M., Tapping R.I., Stepensky V., Nawar H.F., Triantafilou M., et al. Ganglioside GD1a is an essential coreceptor for toll-like receptor 2 signaling in response to the B subunit of Type IIB enterotoxin. J Biol Chem 282 (2007) 7532-7542
12. Liang S., Wang M., Triantafilou K., Triantafilou M., Nawar H.F., Russell M.W., et al. The A subunit of Type IIb enterotoxin (LT-IIb) suppresses the proinflammatory potential of the B subunit and its ability to recruit and interact with TLR2. J Immunol 178 8 (2007) 4811-4819
13. Martin M., Metzger D.J., Michalek S.M., Connell T.D., and Russell M.W. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb. Infect Immun 68 1 (2000) 281-287
14. Triadafilopoulos G., Pothoulakis C., Weiss R., Giampaolo C., and Lamont J.T. Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum. Gastroenterology 97 5 (1989) 1186-1192
15. Satchell K.J. Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins. Microbes Infect 5 13 (2003) 1241-1247
16. Iwasaki A., and Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 5 10 (2004) 987-995
17. Kaisho T., and Akira S. Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 1589 1 (2002) 1-13
18. Hajishengallis G., Koga T., and Russell M.W. Affinity and specificity of the interactions between Streptococcus mutans antigen I/II and salivary components. J Dent Res 73 9 (1994) 1493-1502
19. Russell M.W., Bergmeier L.A., Zanders E.D., and Lehner T. Protein antigens of Streptococcus mutans: purification and properties of a double antigen and its protease-resistant component. Infect Immun 28 2 (1980) 486-493
20. Nawar H.F., Arce S., Russell M.W., and Connell T.D. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities. Infect Immun 73 3 (2005) 1330-1342
21. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223 1 (1999) 77-92
22. Hajishengallis G., Tapping R.I., Harokopakis E., Nishiyama S.-I., Ratti P., Schifferle R.E., et al. Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Toll-like receptor 2-centred pattern recognition apparatus. Cell Microbiol 8 10 (2006) 1557-1570
23. Wang M., and Hajishengallis G. Lipid raft-dependent uptake, signaling, and intracellular fate of Porphyromonas gingivalis in mouse macrophages. Cell Microbiol 10 10 (2008) 2029-2042
24. Hajishengallis G., Hollingshead S.K., Koga T., and Russell M.W. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol 154 9 (1995) 4322-4332
25. Kwissa M., Kasturi S.P., and Pulendran B. The science of adjuvants. Expert Rev Vaccines 6 5 (2007) 673-684
26. Liang S., Hosur K.B., Lu S., Nawar H.F., Weber B.R., Tapping R.I., et al. Mapping of a microbial protein domain involved in binding and activation of the TLR2/TLR1 heterodimer. J Immunol 182 (2009) 2978-2985
27. Akira S., and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4 7 (2004) 499-511
28. Powell J.D., Ragheb J.A., Kitagawa-Sakakida S., and Schwartz R.H. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol Rev 165 (1998) 287-300
29. Fujii S., Liu K., Smith C., Bonito A.J., and Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199 12 (2004) 1607-1618
30. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
31. Coyle A.J., Lehar S., Lloyd C., Tian J., Delaney T., Manning S., et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13 1 (2000) 95-105
32. + T cell populations lacking helper function. Nat Immunol 6 2 (2005) 163-170
33. Steinman R.M., Turley S., Mellman I., and Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191 3 (2000) 411-416
34. Michelsen K.S., Aicher A., Mohaupt M., Hartung T., Dimmeler S., Kirschning C.J., et al. The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem 276 28 (2001) 25680-25686
35. Hertz C.J., Kiertscher S.M., Godowski P.J., Bouis D.A., Norgard M.V., Roth M.D., et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol 166 (2001) 2444-2450
36. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning T.L., Oswald-Richter K., et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 116 4 (2006) 916-928
37. O'Neill L.A., and Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7 5 (2007) 353-364
38. Lavelle E.C., Jarnicki A., McNeela E., Armstrong M.E., Higgins S.C., Leavy O., et al. Effects of cholera toxin on innate and adaptive immunity and its application as an immunomodulatory agent. J Leukoc Biol 75 5 (2004) 756-763
39. Ryan E.J., McNeela E., Pizza M., Rappuoli R., O'Neill L., and Mills K.H. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity. J Immunol 165 10 (2000) 5750-5759
40. Lavelle E.C., McNeela E., Armstrong M.E., Leavy O., Higgins S.C., and Mills K.H. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation. J Immunol 171 5 (2003) 2384-2392
41. Holmgren J., Czerkinsky C., Eriksson K., and Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 21 Suppl. 2 (2003) S89-S95
42. Arce S., Nawar H.F., Muehlinghaus G., Russell M.W., and Connell T.D. In vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of IFN-γ synthesis. Infect Immun 75 3 (2007) 1413-1423
43. Rappuoli R., Pizza M., Douce G., and Dougan G. Structural and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today 20 (1999) 493-500
44. Simmons C.P., Ghaem-Magami M., Petrovska L., Lopes L., Chain B.M., Williams N.A., et al. Immunomodulation using bacterial enterotoxins. Scand J Immunol 53 3 (2001) 218-226
45. Hajishengallis G., and Russell M.W. Molecular approaches to vaccination against oral infections. In: Rogers A. (Ed). Molecular oral microbiology (2008), Caister Academic Press, Norfolk, UK 257-285